Researchers have analyzed the clinical characteristics of Zika infection in Canadian travelers returning from the Americas, discovering that severe complications might be more common than previously estimated.
Researchers from Durham University have developed a new, simplified production process for a drug vital to treating cryptococcal meningitis; they hope this will reduce the drug’s cost and increase its availability in developing countries.
Researchers have discovered a novel regulator of the innate immune response that may lead to the development of new antivirals and vaccines.
Researchers have uncovered the role of inflammasome activation in leishmaniasis progression and severity, demonstrating that inhibiting these pathways may present a potential avenue for future treatments.
The WHO has published a report this week listing 12 families of antibiotic-resistant bacteria that are thought to pose the greatest public health risk and should be the focus for new treatments.
Researchers have suggested that exposure to Listeria may pose a greater risk of complications in early pregnancy than previously appreciated.
The National Institutes of Health (MD, USA) have begun a Phase I clinical trial examining a vaccine intended to provide broad protection against a range of mosquito-borne diseases by targeting the insect’s saliva.
Researchers have utilized a novel mouse model to demonstrate that Zika infection during early pregnancy could lead to higher risk of miscarriage in addition to thin brain tissue and brain inflammation in infants.
Researchers have demonstrated that nanoparticles, such as those from burning fossil fuels, appear to reactivate latent herpesviruses in lung tissue.